Synthesis of novel drug-free cancer targeting nanotherapeutics
Cancer remains the leading cause of death worldwide. Mesoporous silica nanoparticles (MSNs) are seen as one of the promising candidates for anti-cancer therapy, due to its favourable cancer-killing properties. In this research paper, MSNs are being further modified, through attachment of PEG (Polyet...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | |
| التنسيق: | Final Year Project |
| اللغة: | English |
| منشور في: |
Nanyang Technological University
2020
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://hdl.handle.net/10356/139298 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| الملخص: | Cancer remains the leading cause of death worldwide. Mesoporous silica nanoparticles (MSNs) are seen as one of the promising candidates for anti-cancer therapy, due to its favourable cancer-killing properties. In this research paper, MSNs are being further modified, through attachment of PEG (Polyethylene Glycol) chains, in efforts to increase its ability to cause cancer cell death in-vivo, by reducing aggregation and therefore increasing the stability of MSNs. Preliminary in vitro results indicate that PEG conjugation can significantly enhance the stability of MSN in water as well as physiologically-emulated phosphate-buffered saline (PBS). These data lay a solid foundation for the follow-up fabrication of cancer-targeting physiologically-stable silica nanomedicine. |
|---|